Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake R Morgan

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Health Services Research|July 6, 2023
Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019Avik Chatterjee, Shapei Yan, Audrey Lambert, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2024
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United StatesChristina E Freibott, Ali Jalali, Sean M Murphy, et al.
Addiction (Abingdon, England)|August 28, 2023
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USAXiao Zang, Alexander Y Walley, Avik Chatterjee, et al.
Drug and Alcohol Dependence Reports|November 7, 2022
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York CityJake R Morgan, Christina E Freibott, Ali Jalali, et al.
Drug and Alcohol Dependence Reports|June 11, 2025
Care management staff perspectives on stigma and barriers to substance use treatment experienced by latine adults who use substancesChristina S Lee, Erika G Cordova-Ramos, Damaris J Rohsenow, et al.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
Addiction (Abingdon, England)|October 25, 2024
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United StatesXiao Zang, Alexandra Skinner, Zongbo Li, et al.
Addiction (Abingdon, England)|November 26, 2021
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode IslandShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
The New England Journal of Medicine|September 10, 2025
Medications for Opioid Use Disorder in County Jails - Outcomes after ReleasePeter D Friedmann, Donna Wilson, Thomas J Stopka, et al.
JAMA Network Open|May 30, 2024
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid SettlementXiao Zang, Alexandra Skinner, Maxwell S Krieger, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Health Services Research|July 6, 2023
Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019Avik Chatterjee, Shapei Yan, Audrey Lambert, et al.
Journal of the American Pharmacists Association : Japha|April 11, 2024
The association between naloxone claims and proportion of independent versus chain pharmacies: A longitudinal analysis of naloxone claims in the United StatesChristina E Freibott, Ali Jalali, Sean M Murphy, et al.
Addiction (Abingdon, England)|August 28, 2023
Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USAXiao Zang, Alexander Y Walley, Avik Chatterjee, et al.
Drug and Alcohol Dependence Reports|November 7, 2022
The role of increasing pharmacy and community distributed naloxone in the opioid overdose epidemic in Massachusetts, Rhode Island, and New York CityJake R Morgan, Christina E Freibott, Ali Jalali, et al.
Drug and Alcohol Dependence Reports|June 11, 2025
Care management staff perspectives on stigma and barriers to substance use treatment experienced by latine adults who use substancesChristina S Lee, Erika G Cordova-Ramos, Damaris J Rohsenow, et al.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
Addiction (Abingdon, England)|October 25, 2024
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United StatesXiao Zang, Alexandra Skinner, Zongbo Li, et al.
Addiction (Abingdon, England)|November 26, 2021
Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode IslandShayla Nolen, Xiao Zang, Avik Chatterjee, et al.
The New England Journal of Medicine|September 10, 2025
Medications for Opioid Use Disorder in County Jails - Outcomes after ReleasePeter D Friedmann, Donna Wilson, Thomas J Stopka, et al.
JAMA Network Open|May 30, 2024
Evaluation of Strategies to Enhance Community-Based Naloxone Distribution Supported by an Opioid SettlementXiao Zang, Alexandra Skinner, Maxwell S Krieger, et al.
Pageof 8